Oncopeptides AB to Present Data from OCEAN Study at International Myeloma Workshop (IMW) Transcript
Good afternoon, and good morning, everyone. I'm Marty Duvall, CEO of Oncopeptides. And welcome to the Oncopeptides' post IMW Webcast.
Yesterday at the IMW meeting here in Vienna, Dr. Fredrik Schjesvold presented a late-breaking abstract on the OCEAN data set, representing the first introduction of trial details in a peer-reviewed public setting. Over the past 24 hours, we have been pleased to hear the feedback on this excellent presentation, as well as the strong interest in the OCEAN data results.
Today, you will have the opportunity to hear directly from Dr. Fredrik Schjesvold and participate in a Q&A on the data and perspectives. And to present your question, there's a form in the webcast where you can type it in, and we'll have the opportunity to talk about it.
If you could flip the slide forward. Importantly, we will be making some forward-looking statements today. So, please refer to all of our submissions for appropriate balance on representations and warranties of the data as we describe it.
Next slide, please. So, the format today will be that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |